White House: Trump remains committed to Medicare drug price negotiations
President Trump is sticking to his guns on getting Medicare to negotiate drug prices.
During a recent sit-down with Big Pharma execs, the president made a reference to price fixing by Medicare that caused some observers to say that he was backing off a commitment to take the cuffs off the big federal health program for seniors and get them to leverage lower prices on therapeutics — which he feels have become outrageously high.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.